The influence of psychological stress on arginine vasopressin concentration in the human plasma and cerebrospinal fluid

Neuropeptides

Volumn 48, Issue 6, 2014, Pages 361-369

  Bao, Le Le ^a   Jiang, Wen Quan ^a   Sun, Fang Jie ^b   Wang, Da Xin ^c   Pan, Yan Juan ^d   Song, Zhi Xiu ^e   Wang, Chang Hong ^f   Yang, Jun ^b,g  

^a The 153 Central Hospital of Chinese PLA   (China)

^b Xinxiang Institute for New Medicine   (China)

^c YANGZHOU UNIVERSITY   (China)

^d XINXIANG MEDICAL UNIVERSITY   (China)

^e The First Affiliated Hospital of Xinxiang Medical University   (China)

^f Henan Mental Hospital   (China)

^g Standard Technological Co Ltd   (China)

Author keywords

Arginine vasopressin; Blood pressure; Cortisol; Heart rate; Psychological stress

Indexed keywords

ARGIPRESSIN; HYDROCORTISONE;

ADULT; ARGIPRESSIN BLOOD LEVEL; ARGIPRESSIN RELEASE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CEREBROSPINAL FLUID; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HEART RATE; HORMONE BLOOD LEVEL; HORMONE RELEASE; HUMAN; HYDROCORTISONE BLOOD LEVEL; MALE; MENTAL STRESS; NORMAL HUMAN; SYSTOLIC BLOOD PRESSURE; ADOLESCENT; BLOOD; BLOOD PRESSURE; YOUNG ADULT;

ADOLESCENT; ADULT; ARGININE VASOPRESSIN; BLOOD PRESSURE; FEMALE; HEART RATE; HUMANS; HYDROCORTISONE; MALE; STRESS, PSYCHOLOGICAL; YOUNG ADULT;

EID: 84919634558     PISSN: 01434179     EISSN: 15322785     Source Type: Journal    
DOI: 10.1016/j.npep.2014.09.006     Document Type: Article

References (86)

1. Alonso G., Assenmacher I. Radioautographic studies on the neurohypophysial projections of the supraoptic and paraventricular nuclei in the rat. Cell Tissue Res 1981, 219:525-534.
2. Antoni F.A. Hypothalamic control of adrenocorticotropin secretion: advances since the discovery of 41-residue corticotropin-releasing factor. Endocr. Rev 1986, 7:351-378.
3. Antoni F.A. Vasopressinergic control of pituitary adrenocorticotropin secretion comes of age. Front. Neuroendocrinol 1993, 14:76-122.
4. Bradesi S., Martinez V., Lao L., Larsson H., Mayer E.A. Involvement of vasopressin 3 receptors in chronic psychological stress-induced visceral hyperalgesia in rats. Am. J. Physiol. Gastrointest. Liver Physiol 2009, 296:G302-G309.
5. Buijs R.M., Hermes M.L.H.J., Kalsbeek A., van der Woude T., van Heerikhuize J.J. Vasopressin, distribution, origin and functions in the central nervous system. Vasopression, Colloque INSERM 1991, vol. 20:149-158. John Libbey Eurotext Lt.
6. Caffe A.R., Van Leeuwen F.W., Luiten P.G.M. Vasopressin cells in the medial amygdala of the rat project to the lateral septum and ventral hippocampus. J. Comp. Neurol 1987, 261:237-252.
7. Cameron V., Espiner E.A., Nicholls M.G., Donald R.A., MacFarlane M.R. Stress hormones in blood and cerebrospinal fluid of conscious sheep: effect of hemorrhage. Endocrinology 1985, 116:1460-1465.
8. Chandola T., Heraclides A., Kumari M. Psychophysiological biomarkers of workplace stressors. Neurosci. Biobehav. Rev 2010, 35:51-57.
9. Chappell P.B., Smith M.A., Kilts C.D., Bissette G., Ritchie J., Anderson C., et al. Alterations in corticotropin-releasing factor-like immunoreactivity in discrete brain regions after acute and chronic stress. J. Neurosci 1986, 6:2908-2914.
10. Corson S.A., Corson E.O., Hajek J., Hajkova M. The function of vasopressin in adaptation to emotional stress. Act. Nerv. Super. (Praha.) 1977, 19:302-304.
11. Cunningham E.T., Sawchenko P.E. Reflex control of magnocellular vasopressin and oxytocin secretion. Trends Neurosci 1991, 14:406-411.
12. de Kloet E.R. Hormones and the stressed brain. Ann. N. Y. Acad. Sci 2004, 1018:1-15.
13. de Vries G.J., van Leeuwen F.W., Caffe A.R., Swaab D.F. The vasopressinergic innervation of the brain in normal and castrated rats. J. Comp. Neurol 1985, 233:236-254.
14. de Wied D., Diamant M., Fodor M. Central effects of the neurohypophyseal hormones and related peptides. Front. Neuroendocrinol 1993, 14:251-302.
15. Dampney R.A., Horiuchi J., McDowall L.M. Hypothalamic mechanisms coordinating cardiorespiratory function during exercise and defensive behaviour. Auton. Neurosci 2008, 142:3-10.
16. Dockray S., Steptoe A. Positive affect and psychobiological processes. Neurosci. Biobehav. Rev 2010, 35:69-75.
17. Engelmann M., Wotjak C.T., Neumann I., Ludwig M., Landgraf R. Behavioral consequences of intracerebral vasopressin and oxytocin: focus on learning and memory. Neurosci. Biobehav. Rev 1996, 20:341-358.
18. Feldman S., Weidenfeld J. The excitatory effects of the amygdala on hypothalamo-pituitary-adrenocortical responses are mediated by hypothalamic norepinephrine, serotonin, and CRF-41. Brain Res. Bull 1998, 45:389-393.
19. Gibbs D.M. Dissociation of oxytocin, vasopressin and corticotropin secretion during different types of stress. Life Sci 1984, 35:487-491.
20. Gibbs D.M. Vasopressin and oxytocin: hypothalamic modulators of the stress response: a review. Psychoneuroendocrinology 1986, 11:131-139.
21. Gibbs D.M., Vale W., Rivier J., Yen S.S. Oxytocin potentiates the ACTH-releasing activity of CRF(41) but not vasopressin. Life Sci 1984, 34:2245-2249.
22. Gillies G.E., Linton E.A., Lowry P.J. Corticotropin-releasing activity of the new CRF is potentiated several times by vasopressin. Nature 1982, 299:355-357.
23. Greene J.G., Smith R., Gardiner M., Timbury G.C. Measuring behavioural disturbance of elderly demented patients in the community and its effects on relatives: a factor analytic study. Age. Ageing 1982, 11:121-126.
24. Gruber K.A., Eskeridge S.L. Activation of central vasopressin system: a common pathway for centrally acting pressor agents. Am. J. Physiol 1986, 251:R476-R480.
25. Hallbeck M., Hermanson O., Blomquist A. Distribution of preprovasopressin mRNA in the rat central nervous system. J. Comp. Neurol 1999, 411:181-200.
26. Hatton G.I. Emerging concepts of structure-function dynamics in adult brain: the hypothalamo-neurohypophysial system. Prog. Neurobiol 1990, 34:437-504.
27. Hatzinger M., Wotjak C.T., Naruo T., Simchen R., Keck M.E., Landgraf R., et al. Endogenous vasopressin contributes to hypothalamic-pituitary-adrenocortical alterations in aged rats. J. Endocrinol 2000, 164:197-205.
28. Heinrichs M., Domes G. Neuropeptides and social behaviour: effects of oxytocin and vasopressin in humans. Prog. Brain Res 2008, 170:337-350.
29. Herman J.P. In situ hybridization analysis of vasopressin gene transcription in the paraventricular and supraoptic nuclei of the rat: regulation by stress and glucocorticoids. J. Comp. Neurol 1995, 363:15-27.
30. Herman J.P., Schafer M.K.H., Thompson R.C., Watson S.J. Rapid regulation of CRH gene expression in vivo. Mol. Endocrinol 1992, 6:1061-1069.
31. Herman J.P., Flak J., Jankord R. Chronic stress plasticity in the hypothalamic paraventricular nucleus. Prog. Brain Res 2008, 170:353-364.
32. Klein L.A., Rith J., Peterson I.J. Radioimmunoassay of arginine vasopressin (antidiuretic hormone). Surg. Forum 1966, 17:240-242.
33. Kormos V., Gaszner B. Role of neuropeptides in anxiety, stress, and depression: from animals to humans. Neuropeptides 2013, 47:401-419.
34. Kovacs K.J., Sawchenko P.E. Sequence of stress-induced alterations in indices of synaptic and transcriptional activation in parvocellular neurosecretory neurons. J. Neurosci 1995, 16:262-273.
35. Kubzansky L.D., Adler G.K. Aldosterone: a forgotten mediator of the relationship between psychological stress and heart disease. Neurosci. Biobehav. Rev 2010, 34:80-86.
36. Landgraf R. Intracerebrally released vasopressin and oxytocin: measurement, mechanisms and behavioural consequences. J. Neuroendocrinol 1995, 7:243-253.
37. Landgraf R., Neumann I.D. Vasopressin and oxytocin release within the brain: a dynamic concept of multiple and variable modes of neuropeptide communication. Front. Neuroendocrinol 2004, 25:150-176.
38. Landgraf R., Neumann I.D., Schwarzberg H. Central and peripheral release of vasopressin and oxytocin in the conscious rat after osmotic stimulation. Brain Res 1988, 457:219-225.
39. Landgraf R., Gerstberger R., Montkowski A., Probst J.C., Wotjak C.T., Holsboer F., et al. V1 vasopressin receptor antisense oligonucleotide into septum reduces vasopressin binding, social discrimination abilities, and anxiety-related behavior in rats. J. Neurosci 1995, 15:4250-4258.
40. Liard J.F. Vasopressin in cardiovascular control: role of circulating vasopressin. Clin. Sci. (Lond.) 1984, 67:473-481.
41. Ludwig M., Callahan M.F., Neumann I.D., Landgraf R., Morris M. Systemic osmotic stimulation increases vasopressin and oxytocin release within the supraoptic nucleus. J. Neuroendocrinol 1994, 6:369-373.
42. Martin S.M., Malkinson T.J., Veale W.L., Pittman Q.J. The action of centrally administered arginine vasopressin on blood pressure in the conscious rabbits. Am. J. Nephrol 1985, 348:137-145.
43. Matousek R.H., Dobkin P.L., Pruessner J. Cortisol as a marker for improvement in mindfulness-based stress reduction. Complement. Ther. Clin. Pract 2010, 16:13-19.
44. McEwen B.B. The Roles of Vasopressin and Oxytocin in Memory Processing 2004, vol. 50. Elsevier, Amsterdam.
45. Merali Z., Kent P., Du L., Hrdina P., Palkovits M., Faludi G., et al. Corticotropin-releasing hormone, arginine vasopressin, gastrin-releasing peptide, neurmedin B alterations in stress-relevant brain regions of suicides and control subjects. Biol. Psychiatry 2006, 59:594-602.
46. Morin S.M., Stotz-Potter E.H., DiMicco J.A. Injection of muscimol in dorsomedial hypothalamus and stress-induced Fos expression in paraventricular nucleus. Am. J. Physiol. Regul. Integr. Comp. Physiol 2001, 280:R276-R284.
47. Nemenoff R.A. Vasopressin signaling pathways in vascular smooth muscle. Front. Biosci 1998, 3:d194-d207.
48. Neumann I.D., Landgraf R. Advances in vasopressin and oxytocin-from genes to behaviour to disease. Preface. Prog. Brain Res 2008, 170:xi-xiii.
49. Neumann I.D., Ludwig M., Pittman Q.J., Landgraf R. Simultaneous microdialysis in blood and brain: oxytocin and vasopressin release in response to central and peripheral osmotic stimulation and suckling in the rat. Neuroendocrinology 1993, 58:637-645.
50. Noszczyk B., Lon S., Szczepanska-Sadowska E. Central cardiovascular effects of AVP and AVP analogs with V1, V2 and "V3" agonistic or antagonistic properties in conscious dogs. Brain Res 1993, 610:115-126.
51. Oghlakian G., Klapholz M. Vasopressin and vasopressin receptor antagonists in heart failure. Cardiol. Rev 2009, 17:10-15.
52. Okada S., Murakami Y., Nakamura K., Yokotani K. Vasopressin V1-receptor-mediated activation of central sympatho-adrenomedullary outflow in rats. Eur. J. Pharmacol 2002, 457:29-35.
53. Onaka T., Hamamura M., Yagi K. Potentiation of vasopressin secretion by footshock in rats. Jpn J. Physiol 1986, 36:1253-1260.
54. Oreland S., Gustafsson-Ericson L., Nylander I. Short- and long-term consequences of different early environmental conditions on central immunoreactive oxytocin and arginine vasopressin levels in male rats. Neuropeptides 2010, 44:391-398.
55. Pacak K., Palkovits M. Stressor specificity of central neuroendocrine responses: implications for stress-related disorders. Endocr. Rev 2001, 22:502-548.
56. Parrott A.C. Cortisol and 3,4-methylenedioxymethamphetamine: neurohormonal aspects of bioenergetic stress in ecstasy users. Neuropsychobiology 2009, 60:148-158.
57. Plotsky P.M. Pathways to the secretion of adrenocorticotropin: a view from the portal. J. Neuroendocrinol 1991, 3:1-9.
58. Plotsky P.M., Sawchenko P.E. Hypophysial-portal plasma levels, median eminence content, and immunohistochemical staining of corticotropin-releasing factor, arginine vasopressin, and oxytocin after pharmacological adrenalectomy. Endocrinology 1987, 120:1361-1369.
59. Purba J.S., Hoogendijk W.J., Hofman M.A., Swaab D.F. Increased number of vasopressin- and oxytocin-expressing neurons in the paraventricular nucleus of the hypothalamus in depression. Arch. Gen. Psychiatry 1996, 53:137-143.
60. Ramos Q.A.T., Troncone L.R., Tufik S. Suppression of adrenocorticotrophic hormone secretion by simultaneous antagonism of vasopressin V1b and CRH-1 receptors on three different stress models. Neuroendocrinology 2006, 84:309-316.
61. Romero L.M., Plotsky P.M., Sapolsky R.M. Patterns of adrenocorticotropin secretagog release with hypoglycemia, novelty, and restraint after colchicine blockade of axonal transport. Endocrinology 1993, 132:199-204.
62. Roper J., O'Carroll A.M., Young W., Lolait S. The vasopressin Avpr1b receptor: molecular and pharmacological studies. Stress 2011, 14:98-115.
63. Scantamburlo G., Ansseau M., Legros J.J. Role of the neurohypophysis in psychological stress. Encephale 2001, 27:245-259.
64. Serradeil-Le Gal C., Wagnon J., Tonnerre B., Roux R., Garcia G., Griebel G., et al. An overview of SSR149415, a selective nonpeptide vasopressin V1b receptor antagonist for the treatment of stress-related disorders. CNS Drug Rev 2005, 11:53-68.
65. Sofroniew M.V. Vasopressin and oxytocin in the mammalian brain and spinal cord. Trends Neurosci 1983, 6:467-472.
66. Swanson L.W. Biochemical switching in hypothalamic circuits mediating responses to stress. Prog. Brain Res 1991, 87:181-200.
67. Swanson L.W., Sawchenko P.E. Hypothalamic integration: organization of the paraventricular and supraoptic nuclei. Annu. Rev. Neurosci 1983, 6:269-324.
68. Szczepanska-Sadowska E. Interaction of vasopressin and angiotensin II in central control of blood pressure and thirst. Regul. Pept 1996, 66:65-71.
69. Szczepanska-Sadowska E. Neuropeptides in neurogenic disorders of the cardiovascular control. J. Physiol. Pharmacol 2006, 57(Suppl. 11):31-54.
70. Szczepanska-Sadowska E. Role of neuropeptides in central control of cardiovascular responses to stress. J. Physiol. Pharmacol 2008, 59(Suppl. 8):61-89.
71. Szczepanska-Sadowska E., Gray D., Simon-Oppermann C.H. Vasopressin in blood and third ventricle during dehydration, thirst, and haemorrhage. Am. J. Physiol 1983, 245:R549-R555.
72. Szczepanska-Sadowska E., Paczwa P., Lon S., Ganten D. Increased pressor function of central vasopressinergic system in hypertensive renin transgenic rats. J. Hypertens 1998, 16:1505-1514.
73. Toba K., Ohta M., Kimura T., Nagano K., Ito S., Ouchi Y. Role of brain vasopressin in regulation of blood pressure. Prog. Brain Res 1998, 119:337-349.
74. van Londen L., Goekoop J.G., van Kempen G.M., Frankhuijzen-Sierevogel A.C., Wiegant V.M., van der Velde E.A., et al. Plasma levels of arginine vasopressin elevated in patients with major depression. Neuropsychopharmacology 1997, 17:284-292.
75. van Londen L., Goekoop J.G., Kerkhof G.A., Zwinderman K.H., Wiegant V.M., De Wied D. Week 24-h periodicity of body temperature and increased plasma vasopressin in melancholic depression. Eur. Neuropsychopharmacol 2001, 11:7-14.
76. Volpi S., Rabadan-Diehl C., Aguilera G. Vasopressinergic regulation of the hypothalamic pituitary adrenal axis and stress adaptation. Stress 2004, 7:75-83.
77. Wang J., Tai F., Lai X. Cocaine withdrawal influences paternal behavior and associated central expression of vasopressin, oxytocin and tyrosine hydroxylase in mandarin voles. Neuropeptides 2014, 48:29-35.
78. Whitnall M.H. Regulation of the hypothalamic corticotropin-releasing hormone neurosecretory system. Prog. Neurobiol 1993, 40:573-629.
79. Wotjak C.T., Kubota M., Liebsch G., Montkowski A., Holsboer F., Neumann I.D., et al. Release of vasopressin within the rat parventricular nucleus in response to emotional stress: a novel mechanism of regulating adrenocorticotropic hormone secretion?. J. Neurosci 1996, 16:7725-7732.
80. Wotjak C.T., Ganster J., Kohl G., Holsboer F., Landgraf R., Engelmann M. Dissociated central and peripheral release of vasopressin, but not oxytocin, in response to repeated swim stress: new insights into the secretory capacities of peptidergic neurons. Neuroscience 1998, 85:1200-1222.
81. Yang J., Song C.Y., Liu W.Y., Lin B.C. Only through the brain nuclei, arginine vasopressin regulates antinociception in the rat. Peptides 2006, 27:3341-3346.
82. Yang J., Yang Y., Wang C.H., Wang G., Xu H.T., Liu W.Y., et al. Effect of arginine vasopressin on acupuncture analgesia in the rat. Peptides 2009, 30:241-247.
83. Yang J., Pan Y.J., Yin Z.K., Hai G.F., Lu L., Zhao Y., et al. Effect of arginine vasopressin on the behavioral activity in the behavior despair depression rat model. Neuropeptides 2012, 46:141-149.
84. Yayou K., Nakamura M., Ito S. Effects of AVP V1a and CRH receptor antagonist on psychological stress responses to frustrating condition in sheep. J. Vet. Med. Sci 2009, 71:431-439.
85. Ziegler D.R., Cullinan W.E., Herman J.P. Distribution of vesicular glutamate transporter mRNA in rat hypothalamus. J. Comp. Neurol 2002, 448:217-229.
86. Zimmermann U., Spring K., Wittchen H.U., Himmerich H., Landgraf R., Uhr M., et al. Arginine vasopressin and adrenocorticotropin secretion in response to psychosocial stress is attenuated by ethanol in sons of alcohol-dependent fathers. J. Psychiatr. Res 2004, 38:385-393.